An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

MLA

Yingwei Hu, et al. “An Integrated Proteomic and Glycoproteomic Approach Uncovers Differences in Glycosylation Occupancy from Benign and Malignant Epithelial Ovarian Tumors.” Clinical Proteomics, vol. 14, May 2017. EBSCOhost, https://doi.org/10.1186/s12014-017-9152-2.

APA

Yingwei Hu, Hui Zhang, Punit Shah, Yuan Tian, Qing Kay Li, Richard B. S. Roden, & Daniel W. Chan. (2017). An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors. Clinical Proteomics, 14. https://doi.org/10.1186/s12014-017-9152-2

Chicago

Yingwei Hu, Hui Zhang, Punit Shah, Yuan Tian, Qing Kay Li, Richard B. S. Roden, and Daniel W. Chan. 2017. “An Integrated Proteomic and Glycoproteomic Approach Uncovers Differences in Glycosylation Occupancy from Benign and Malignant Epithelial Ovarian Tumors.” Clinical Proteomics 14 (May). doi:10.1186/s12014-017-9152-2.